These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25492294)

  • 1. [Comparative study on functional characters of MCF7 and HCC1937 cell lines in response to DNA damage].
    Dong C; Zhang F; Zhao X; Guo G; Luo Y; Feng Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Sep; 48(9):809-14. PubMed ID: 25492294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ionizing radiation inhibits the PLK cell cycle gene in a G2 checkpoint-dependent manner.
    Ree AH; Bratland A; Solberg Landsverk K; Fodstad O
    Anticancer Res; 2004; 24(2B):555-62. PubMed ID: 15160994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 is involved in clearance of ionizing radiation-induced RAD51 foci in a human colon cancer cell line.
    Orre LM; Stenerlöw B; Dhar S; Larsson R; Lewensohn R; Lehtiö J
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1211-7. PubMed ID: 16516153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 suppresses hyper-recombination by modulating BRCA1 function.
    Dong C; Zhang F; Luo Y; Wang H; Zhao X; Guo G; Powell SN; Feng Z
    DNA Repair (Amst); 2015 Sep; 33():60-9. PubMed ID: 26162908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.
    DelloRusso C; Welcsh PL; Wang W; Garcia RL; King MC; Swisher EM
    Mol Cancer Res; 2007 Jan; 5(1):35-45. PubMed ID: 17259345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation.
    Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB
    Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo.
    Yuan SS; Lee SY; Chen G; Song M; Tomlinson GE; Lee EY
    Cancer Res; 1999 Aug; 59(15):3547-51. PubMed ID: 10446958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1.
    Ree AH; Bratland A; Nome RV; Stokke T; Fodstad Ø
    Oncogene; 2003 Dec; 22(55):8952-5. PubMed ID: 14654792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage induces p53-dependent BRCA1 nuclear export.
    Feng Z; Kachnic L; Zhang J; Powell SN; Xia F
    J Biol Chem; 2004 Jul; 279(27):28574-84. PubMed ID: 15087457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells.
    Brew CT; Aronchik I; Hsu JC; Sheen JH; Dickson RB; Bjeldanes LF; Firestone GL
    Int J Cancer; 2006 Feb; 118(4):857-68. PubMed ID: 16152627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular responses of BRCA1-defective and triple-negative breast cancer cells and in vitro BRCA1 interactions induced by metallo-intercalator ruthenium(II) complexes containing chloro-substituted phenylazopyridine.
    Nhukeaw T; Temboot P; Hansongnern K; Ratanaphan A
    BMC Cancer; 2014 Feb; 14():73. PubMed ID: 24507701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma.
    Sun Y; Tran BN; Worley LA; Delston RB; Harbour JW
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1561-4. PubMed ID: 15851551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer.
    Guney Eskiler G; Cecener G; Egeli U; Tunca B
    Pharm Res; 2018 Sep; 35(11):218. PubMed ID: 30255456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA damage induces BRCA1 distribution alteration in prostate cancer cell lines].
    Wang CY; Sun SK; Fu WJ; Song T; Cai W; Gao JP; Hong BF; Wang XX; Wang H
    Zhonghua Nan Ke Xue; 2008 Aug; 14(8):685-9. PubMed ID: 18817338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The carboxyl-terminal of BRCA1 is required for subnuclear assembly of RAD51 after treatment with cisplatin but not ionizing radiation in human breast and ovarian cancer cells.
    Zhou C; Huang P; Liu J
    Biochem Biophys Res Commun; 2005 Oct; 336(3):952-60. PubMed ID: 16165098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
    Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
    Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Novel Ribonucleotide Reductase Inhibitor COH29 Inhibits DNA Repair In Vitro.
    Chen MC; Zhou B; Zhang K; Yuan YC; Un F; Hu S; Chou CM; Chen CH; Wu J; Wang Y; Liu X; Smith DL; Li H; Liu Z; Warden CD; Su L; Malkas LH; Chung YM; Hu MC; Yen Y
    Mol Pharmacol; 2015 Jun; 87(6):996-1005. PubMed ID: 25814515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential sensitivity of BRCA1-mutated HCC1937 human breast cancer cells to microtubule-interfering agents.
    Tassone P; Blotta S; Palmieri C; Masciari S; Quaresima B; Montagna M; D'Andrea E; Eramo OP; Migale L; Costanzo F; Tagliaferri P; Venuta S
    Int J Oncol; 2005 May; 26(5):1257-63. PubMed ID: 15809716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1-deficient breast cancer cell lines are resistant to MEK inhibitors and show distinct sensitivities to 6-thioguanine.
    Gu Y; Helenius M; Väänänen K; Bulanova D; Saarela J; Sokolenko A; Martens J; Imyanitov E; Kuznetsov S
    Sci Rep; 2016 Jun; 6():28217. PubMed ID: 27313062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.